World News: 14:00 GMT Wednesday 12th June 2019. [MannKind via Globe Newswire via SPi World News]
WESTLAKE VILLAGE, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the JMP Securities Life Sciences Conference at 9:00 AM (ET) on June 19, 2019. The conference is being held at The St. Regis in New York.
Michael Castagna, Chief Executive Officer, of MannKind Corporation, will provide an overview of the Company's business during the live presentation. Steven B. Binder, Chief Financial Officer, will participate in one-on-one meetings with investors who are registered to attend the conference.
The presentation will be webcast live. Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at . The webcast replay will remain available for 14 days following the live presentation.
Source: MannKind Corporation
Globe Newswire: 14:00 GMT Wednesday 12th June 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.